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Dihydrolipoyl acetyltransferase (E2) is the central
component of pyruvate dehydrogenase complex
(PDC), which converts pyruvate to acetyl-CoA. Struc-
tural comparison by cryo-electronmicroscopy (cryo-
EM) of the human full-length and truncated E2 (tE2)
cores revealed flexible linkers emanating from the
edges of trimers of the internal catalytic domains.
Using the secondary structure constraints revealed
in our 8 A˚ cryo-EM reconstruction and the prokary-
otic tE2 atomic structure as a template, we derived
a pseudo atomic model of human tE2. The active
sites are conserved between prokaryotic tE2 and hu-
man tE2. However, marked structural differences are
apparent in the hairpin domain and in the N-terminal
helix connected to the flexible linker. These permuta-
tions away from the catalytic center likely impart
structures needed to integrate a second component
into the inner core and provide a sturdy base for the
linker that holds the pyruvate dehydrogenase for ac-
cess by the E2-bound regulatory kinase/phospha-
tase components in humans.
INTRODUCTION
Pyruvate dehydrogenase complex (PDC) is one of the largest
multienzyme, supramolecular machines found in both prokary-
otes and eukaryotes (Reed, 1974; Patel and Roche, 1990).
PDC belongs to the family of enzymes that catalyzes the oxida-
tive decarboxylation of a-keto acids. By converting pyruvate to
acetyl-coenzyme A (CoA), PDC allows glucose carbons to be
used as an oxidative energy source or in fatty acid biosynthesis.
This catalysis is a key reaction that occurs at the junction of
glycolysis and the citric acid cycle. Because this conversion
leads to a net depletion of glucose carbons in mammals, mam-
malian PDC plays an important gatekeeper role in the irreversible
consumption of carbohydrates (Randle, 1986), and its activity is
tightly regulated by a set of dedicated kinases and phosphatases
(Randle and Priestman, 1996; Roche et al., 2001).104 Structure 16, 104–114, January 2008 ª2008 Elsevier Ltd All righHuman PDC contains six major components: pyruvate dehy-
drogenase (E1), dihydrolipoyl acetyltransferase (E2), dihydroli-
poyl dehydrogenase (E3), E3-binding protein (E3BP), and two
dedicated regulatory components—pyruvate dehydrogenase
kinase (PDK) and pyruvate dehydrogenase phosphatase (PDP)
(Roche et al., 2001, 2003; Kato et al., 2007). E1, E2, and E3 are
found in species ranging from prokaryotes to higher organisms,
and E3BP is found in most eukaryotes. E2 plays a central role by
acting as a scaffold in organizing and connecting the compo-
nents participating in the sequential reactions of the complex
(Yang et al., 1997). In humans, tissue-specific isoforms of PDK
and PDP provide valuable targets for therapeutic intervention
of diabetes, heart ischemia, and cancer (Kato et al., 2007; Roche
and Hiromasa, 2007).
The outer globular domains of human E2 consist of two lipoyl
domains (L1 and L2) and a small E1-binding domain, connected
by alanine- and proline-rich hinge regions that are 20–30
residues in length (Figure 1A) (Thekkumkara et al., 1988). The
composition of lipoyl domains and the roles of the binding
domains vary among E2 from different sources (Perham,
2000). For instance, the number of lipoyl domains per E2 subunit
can be one (yeast, chloroplast, or Bacillus stearothermophilus
PDC), two (mammalian, plant mitochondria, and Streptococcus
faecalis PDC), or three (Escherichia coli or Azotobacter vinelandii
E2). The small binding domain of E2 in eukaryotes and humans
binds only to E1, whereas the structurally related E2 domains
from bacteria can bind to either E1 or E3. The C-terminal half
of E2, which is also called the inner catalytic (IC) domain, shares
less than 35% sequence identity in prokaryotic PDC and human
PDC. Human E3BP is composed of three linker-connected
domains in a configuration similar to that of human E2 (Figure 1A),
and its IC domain has 50% sequence identity with human E2
(Harris et al., 1997). The outer linker regions are responsible for
the delivery of the lipoyl domains, through a ‘‘swinging arm’’
active-site coupling mechanism (Reed and Hackert, 1990), to
the E1, E2, and E3 components, in which the prosthetic group
covalently bound to the lipoyl domain extends into active-site
channels (Roche and Cox, 1996). Every E2 trimer has three
active-site channels located at the three inter-E2 interfaces.
These channels span the distance from the outer surface (lipoyl
group entry) to the interior of the dodecahedron (CoA entry) and
serve as conduits through which acetyl groups pass (Mattevi
et al., 1992).ts reserved
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3D Structures of the Human PDC Cores by Cryo-EMFigure 1. Schematic Diagram of Human E2 and E3BP and Cryo-EM of the Human PDC Core
(A) Schematic diagram of full-length E2 and E3BP molecules. PDK has a stronger binding affinity to L2 of E2 (indicated by a thick, dotted line) than to L1 of E2 and
L3 of E3BP (indicated by thin, dotted lines). The arrow points to the PreScisssion cleavage site of E2.
(B–E) Focal pairs of cryo-EM images of (B and C) recombinant human tE2 and (D and E) full-length E2 cores are shown. The underfocus values for close-to-focus
and far-from-focus images, respectively, were 0.9 and 3.0 mm for tE2 and 1.2 and 3.3 mm for E2. Insets in (E) show one enlarged view of the E2 particle and its
cartoon illustration, revealing peripheral densities (arrows) tethered to cores.The three-dimensional (3D) structures of prokaryotic, yeast,
and bovine PDCs and their subcomplexes have been studied
by X-ray crystallography (Mattevi et al., 1992; Mande et al.,
1996), NMR (Kalia et al., 1993), and cryo-electron microscopy
(cryo-EM) (Wagenknecht et al., 1991; Stoops et al., 1992,
1997; Zhou et al., 2001a; Milne et al., 2002; Borgnia et al.,
2004). These structural analyses have revealed significant evo-
lutionary diversity in structure and subunit composition that
imparts unique regulatory properties in spite of the conserved
enzymatic activities of PDCs (Patel and Roche, 1990). The
E. coli and A. vinelandii PDCs, for example, are built aroundStructure 16an octahedral core of E2 chains to which multiple copies of
E1 and E3 are bound. In contrast, B. stearothermophilus, yeast,
and mammalian E2 complexes form a pentagonal dodecahe-
dron with a large internal cavity. Most notably, the structure
of the truncated E2 (tE2) C-terminal half (i.e., the IC domain)
from A. vinelandii has been determined to atomic resolution
(2.6 A˚) by X-ray crystallography (Mattevi et al., 1992). Atomic
models of B. stearothermophilus and Enterococcus faecalis
tE2 molecules have also been constructed by homology mod-
eling and fitting to X-ray diffraction data at 4.4 A˚ resolution
(Izard et al., 1999)., 104–114, January 2008 ª2008 Elsevier Ltd All rights reserved 105
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3D Structures of the Human PDC Cores by Cryo-EMFunctional human PDC complexes and subcomplexes can be
obtained in solution by incubating individually expressed pro-
teins (Yang et al., 1997). By introducing a PreScission protease
site in the full-length human E2, we were able to obtain a limited
amount of soluble human tE2 cores by chemical cleavage of the
recombinant full-length E2 (Hiromasa et al., 2004). However,
human and other eukaryotic E2 or tE2 cores have eluded X-ray
crystallographic efforts. The intrinsic flexibility of full-length hu-
man E2 may have prevented the formation of crystals suitable
for X-ray diffraction analyses. Attempts to grow crystals of hu-
man tE2 have also been fruitless due to difficulties in obtaining
an adequate quantity of soluble human tE2 cores either by
directly expressing tE2 or by chemically cleaving full-length E2.
Consequently, our understanding of the human E2 structure
has remained limited.
In this study, we used cryo-EM single-particle reconstructions
to obtain the 3D structures of the full-length human E2 and tE2
cores. Comparison of these structures established that human
E2 is organized as a pentagonal dodecahedron of 20 E2 trimers
with a stiff inner linker emanating from the edge of each subunit
of the trimer. Secondary structure elements resolved in our 8 A˚
resolution cryo-EM map were used as constraints to build
a pseudo atomic model of human tE2, which reveals a highly
conserved catalytic center and key structural differences in the
Table 1. Summary of Data Processing of the Human
E2 and tE2 Cores
tE2 E2
Far-from-
Focus
Close-to-
Focus
Far-from-
Focus
Close-to-
Focus
CCD frames used 197 197 100 100
Boxed-out particles 13,199 13,002 5,169 5,054
Particles processed 9,167 2,432 4,080 1,391
Defocus range (mm) 2.7–4.2 0.6–2.1 3.0–4.1 0.9–2.0
B factor range (A˚2) NAa 138–235 NAa 154–240
Resolution (A˚) NAa 8.8 NAa 15
a Not available.106 Structure 16, 104–114, January 2008 ª2008 Elsevier Ltd All righperipheral domains. These structural differences are consistent
with the unique requirements of the human E2, compared with
its prokaryotic homologs, to serve its highly regulated functional
roles. Based on these observations, we have proposed a mech-
anistic model to account for the catalytic and unique regulatory
activities of human PDC.
RESULTS
3D Structures of the Human PDC E2 and tE2 Cores
We imaged the E2 cores assembled with recombinantly ex-
pressed full-length human E2 and N-terminal tE2 (Figure 1A)
subunits that contained only the IC domain. Cryo-EM images
of tE2 (Figures 1B and 1C) and full-length E2 (Figures 1D and
1E) cores showed cage-like structures with the characteristic
pentagonal dodecahedral shape. The contrast of the E2 images
was consistently lower than that of the tE2 images, presumably
because thicker ice was necessary to fully embed the larger
cores containing the full-length E2 subunits. Upon closer exam-
ination of the E2 images, we identified densities that extended
50–80 A˚ from the dodecahedral cores that appeared to be
tethered to the cores (insets in Figure 1E), and this finding is
similar to what has been previously seen in 2D images of bovine
PDC cores (Wagenknecht et al., 1991).
As summarized in Table 1, we determined the 3D structures of
human tE2 and E2 cores by cryo-EM single-particle reconstruc-
tion to an effective resolution of 8.8 A˚ and 15 A˚, respectively. The
lower resolution of the full-length E2 structure is probably due to
the greater molecular flexibility and the lower contrast of its cryo-
EM images resulting from thicker ice. The 3D reconstructions of
tE2 (Figure 2A) and full-length E2 (Figure 2B) cores filtered to the
same resolution appear to be very similar when displayed as
shaded surface representations at the same density threshold
(one standard deviation above the mean). They have the shape
of a dodecahedron cage consisting of 60 E2 subunits arranged
as 20 trimers. In particular, the E2 IC trimer densities are identical
and superimposable in their internal regions. However, the re-
solved E2 structure also appears to contain some extra densitiesFigure 2. 3D Structures of Human PDC
Cores
(A and B) Outer view of a shaded surface represen-
tation of the (A) human tE2 and (B) full-length E2
cores, reconstructed to 15 A˚ resolution. Maps
are color coded according to particle radius. The
E2 core contains additional features (arrowheads)
that are not present in the tE2 structure.
(C) Close-up view of the region surrounding a
trimer shown at a lower-density threshold.
(D) Central slice through the reconstruction in (B),
shown as a gray-level display. Arrowheads in (C)
and (D) indicate the same features as in (B).
(E) A 25 A˚ resolution reconstruction of intact PDC
isolated from bovine tissues. The linker densities
emanate from the E2 core, at the same locations
as revealed in the human E2 core structure (see
[B]–[D]). The linker extensions are more clearly vis-
ible in the bovine PDC structure than in the human
E2 core structure because the extensions are
likely stabilized by binding of E1 (Zhou et al.,
2001a).ts reserved
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3D Structures of the Human PDC Cores by Cryo-EM(indicated by arrowheads in Figure 2B) that were not present in
the tE2 structure. When the density contour level was reduced,
these additional extensions became more apparent, as shown
in the close-up (Figure 2C) and central slice (Figure 2D) of the
full-length E2 reconstructions. We attribute these features,
which emanate from the periphery of the IC trimers, to ordered
segments of the linker between the IC domain and the E1-bind-
ing domain. This linker region was visualized in the cryo-EM
reconstruction of the intact PDC purified from bovine kidney
tissues (Figure 2E). The extra feature on each IC domain seen
in Figures 2C and 2D represents only a partially ordered portion
of the linker. The flexible portion of the linker (Figure 2C) was
further stabilized by binding E1 (Zhou et al., 2001b). In addition
to the linker densities emanating from the edge of the E2 IC
trimer that are only visible in the full-length E2 structure, there
are some minor differences in the outer surface of the trimer
of the tE2 and E2 structures. Interference from the flexibly
positioned outer domains of E2 may account for the more
convoluted appearance of the surface of the E2 inner core
(Figure 2B).
E2 and tE2 can vary in size and conformation, which may limit
the achievable resolution of the reconstruction (Zhou et al.,
2001a; Kong et al., 2003; Borgnia et al., 2004). The dynamic
variation in the structure of the tE2 has been documented
(Zhou et al., 2001a; Kong et al., 2003); human tE2 and the inner
core of full-length E2 exhibit a similar flexibility and variation in
particle diameter. To obtain higher resolution, our final structures
Figure 3. 3D Reconstruction of Human tE2
at 8.8 A˚ Resolution
(A and B) Shaded, radially colored surface repre-
sentation of (A) outside and (B) inside views of
the human tE2 core along a three-fold axis. Sec-
ondary structure elements (cylindrical helices
and globular b sheets) are discernable.
(C and D) (C) Top and (D) side views of two adja-
cent tE2 trimers extracted from the 3D reconstruc-
tion of the tE2 core, viewed along a two-fold axis.
The solid and dashed arrows in (D) indicate the
‘‘ball’’ and ‘‘socket,’’ respectively, of the charac-
teristic interaction between two adjacent trimers.
The dashed oval marks a region with two helices,
which is blown up in the right panel of (E).
(E) Close-ups of the 3D map of human tE2, show-
ing some rod-shaped helix densities. Left: top
view of three H1 helices surrounding a three-fold
axis. Right: side view of the circled area in (D)
showing H4 and H6 helices (see helix numbering
and details in Figures 4 and 6).
(F) Fourier shell correlation coefficient showing
improvement in resolution as the number of parti-
cles increases.
of tE2 and E2 were reconstructed only
from those particles within a 2% size
difference of the most probable size
group, as classified by an iterative size
classification program, sizeDiff (Zhou
et al., 2001a). As expected, the resolu-
tions of both the tE2 and E2 structures
improved when the amount of size varia-
tions among the particles included in the 3D reconstruction
decreased. In addition, extra densities were resolved as definite
features in the E2 structure (discussed below) when only
particles with inner cores within the 0.99–1.01 size group were
used.
Human tE2 Structure at Subnanometer Resolution
Because positions of the lipoyl domains and linker regions are
variable within the full-length E2 structure, we focused on the
tE2 core for our higher-resolution analyses (Figure 3; Movie S1,
see the Supplemental Data available with this article online).
The effective resolution of our 3D structure increased as the
number of particles in our data set increased (Figure 3F), and it
reached 8.8 A˚ for the final data set of 2432 particles. At this
resolution, secondary structure elements of the core, including
a helices (cylindrical rods in Figure 3A) and b sheets (globular
shapes in Figure 3B), are clearly visible. Seven a helices could
be identified in each tE2 subunit; three of these (H1, H4, and
H6) are indicated by dotted lines in Figure 3E. Closer examina-
tion of the individual tE2 trimers revealed points at which interac-
tions between adjacent trimers could be seen (Figures 3C and
3D). In contrast to the intensive, interdigitated associations
among the three monomers within each trimer, the contact be-
tween adjacent trimers is very limited. A short, rod-like structure
(arrow in Figure 3D), which is connected to the C-terminal end of
helix H6 by a turn, interacts with its neighboring two-fold-axis-re-
lated trimer (areas of interaction are indicated by arrows).Structure 16, 104–114, January 2008 ª2008 Elsevier Ltd All rights reserved 107
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3D Structures of the Human PDC Cores by Cryo-EMCryo-EM-Constrained Homology Model of Human tE2
The IC domains of human E2 and prokaryotic E2 (A. vinelandii
and B. stearothermophilus) share 32% of their amino acid se-
quences (Figure 4). We used the SWISS-MODEL protein model-
ing server to generate a homology model of human tE2 from the
known 2.6 A˚ resolution tE2 structure of A. vinelandii (Mattevi
et al., 1992). The homology model was then refined by using
the 8 A˚ cryo-EM 3D map. Without this refinement, the homology
model (e.g., blue ribbon in Figure 5F) contained errors in the po-
sitioning of the secondary structure elements. The disposition
or fold of the secondary structure elements in our final energy
minimized model of the human tE2 core (e.g., ribbons in Figures
5A–5E and gold ribbon in Figure 5F) is more accurately deter-
mined, as indicated by its excellent agreement with experimen-
tally resolved helices and b sheets in the cryo-EM map.
A detailed comparison of our pseudo atomic model of human
tE2 with the atomic model of A. vinelandii tE2 is shown in Figures
6A–6C (also see Movie S2). As expected, the structures at the
active sites are highly conserved, and there are superimposable
helices and b sheets at or near the active sites. For example, the
secondary structure elements form the active sites in A. vinelan-
dii tE2 (Mattevi et al., 1992), in which CoA is shown by stick-and-
ball models, and are fully conserved in the human tE2 structure
(Figure 6C). Similar to A. vinelandii tE2, the active-site pocket
in human tE2 is formed by participation of a helices H3–H5 and
b sheets composed of strands S2–S3 (Figures 6A–6C). Ser480
and His534 from the neighboring tE2 domain are conserved
residues that are responsible for acetyltransferase activity. The
secondary structure elements of the lipoyl group-binding site
are also preserved. An internal b barrel formed by joining
b strands from trimer subunits (Figure 6A) is almost identical to
its A. vinelandii tE2 counterpart, suggesting that the key building
block of tE2 is preserved from prokaryotes to humans. In addi-
tion, the ‘‘spring’’ and ‘‘ball’’ described in the ‘‘ball-and-socket’’
model (Zhou et al., 2001a) are also similar in human and prokary-
otic tE2. This structure, which connects each IC domain of a
Figure 4. Sequence Homology between
Human and Bacterial E2s
Alignment of human, Bacillus stearothermophilus
(B. ste.), and A. vinelandii (A. vin.) tE2 sequences.
Identical residues are bold and capitalized; similar
residues are capitalized only. Helices (H) are indi-
cated by shading; b sheets (S) are indicated by
dotted boxes. The prokaryotic tE2s have two short
b strands between H3 and S2 that are not present
in human tE2, and two other b strands (S6 and S7)
are shorter in human than in prokaryotic tE2.
trimer to the IC domain in its neighboring
trimer along the two-fold axis, is collec-
tively formed by C-terminal helices H6
and H7 in human tE2. The C-terminal hy-
drophobic ‘‘ball’’ (Leu561-Leu560) joins
a 310 helix, helix H7, next to a Pro-con-
taining turn that functions as an elbow in
connecting to helix H6. This entire seg-
ment is proposed to act as a cantilever
with ‘‘spring-like’’ flexibility that is facili-
tated by the rotation of the ‘‘ball’’ sheathed in a hydrophobic
‘‘socket’’ that is provided by the neighboring two-fold-symmetric
subunit (Zhou et al., 2001a).
There are two major regions of difference between the human
and prokaryotic tE2 structures (Figures 6B and 6C). First, there is
a difference in the orientation of the associated H1 helix at the
N terminus of the tE2 molecule. In the A. vinelandii tE2 structure,
the extended N-terminal loop projecting from the H1 helix folds
back to the middle of the trimer. Instead, the 14 residue H1 helix
in human tE2 (residues 343–356) rotates clockwise away from
the five-fold axis by 20, which places H1 closer to its neigh-
boring subunit than the 16 residue H1 helix in A. vinelandii tE2
(residues 417–432) (Figures 5D, 5E, 6B, and 6C). The marked dif-
ference in the N-terminal helix is important for forming a firm
base for the departure of the linker region from this structure,
which is observed with full-sized E2 (see Discussion).
The other major difference concerns the internal domain ex-
tending into the central space of the dodecahedron. In A. vine-
landii, this domain exists as a two-stranded b sheet (Figures
6A, and 6C, labeled as 60 and 70) with a 2 residue turn at its tip,
whereas, in human tE2, it stretches farther as an extended
loop (Figures 5F and 6C). Inside the tE2 trimer, each tE2 subunit
has a cascading set of b strands aligned to form one-third of an
inner b sheet barrel (Figure 6A). The human tE2 end loop or its
correspondingA. vinelandii tE2 end b sheet forms the internal ex-
tension of this b sheet barrel. In the prokaryotic tE2 trimer struc-
ture, the b hairpin bends away from the central axis of the exten-
sion tip. In contrast, the longer human tE2 loops align straight
down the axis of the extension tip with an inward bend (Figures
4, 6A, and 6C), forming a more compact and more extended
inner tip than the prokaryotic tE2 structure.
Aside from these major differences, there are some minor
structural differences worth noting. For example, a kink divides
helix H2 into two parts in A. vinelandii tE2, whereas, in the human
tE2 structure, the C-terminal portion of helix H2 exists as a coil
(labeled as 20 in Figure 6B). Similarly, the long helix H4 in108 Structure 16, 104–114, January 2008 ª2008 Elsevier Ltd All rights reserved
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3D Structures of the Human PDC Cores by Cryo-EMFigure 5. Cryo-EM Density-Restrained Atomic Modeling of Human tE2
(A) Wire-frame representation of a high-resolution cryo-EM density map from Figure 3, superimposed with our cryo-EM-derived pseudo atomic model (gold
ribbon) (also see Movie S1).
(B and C) Close-up views of two neighboring tE2 monomers (in different colors), shown either (B) with or (C) without the cryo-EM density superimposed. Arrows in
(C) indicate the C-terminal helix H7 that is involved in the interaction between two E2 monomers.
(D and E) Close-up views of two representative regions of a single E2 trimer, showing agreement of the disposition of secondary structure elements between the
cryo-EM densities (wire-frame) and the pseudo atomic model (ribbon). Different colors represent structure elements from different tE2 monomers.
(F) Close-up view of the internal hairpin loop region of tE2, showing the cryo-EM density (wire-frame), the unrefined homology model (blue ribbon), and the refined,
cryo-EM-restrained model (gold ribbon).A. vinelandii tE2 corresponds to two shorter helices joined by
a kink in the human tE2 structure (labeled as H4 and H5).
DISCUSSION
Cryo-EM-Constrained Atomic Modeling
Cryo-EM single-particle reconstruction has advanced in recent
years such that density maps can be resolved beyond the sub-
nanometer resolution level, thereby revealing the topological ar-
rangement, or the folds, of secondary structure elements within
protein subunits (e.g., Bo¨ttcher et al., 1997; Zhou et al., 2000,
2003; Cheng et al., 2004; Ludtke et al., 2004). Although these
structures represent a significant technological advancement
in cryo-EM, their value was significantly reduced in the absence
of atomic coordinate information of their structural elements,Structure 16such as an atomic model. Cryo-EM images can now be recorded
near atomic resolution by using state-of-the-art instruments, but
3D single-particle reconstructions at atomic resolution are still
lacking, largely because of the exponential increase in the
amount of image data that need to be processed accurately
for higher-resolution structure determination. In the favorable sit-
uation in which the structures of homologous or at least remotely
homologous molecules have been determined to atomic resolu-
tion by the complementary techniques of NMR and X-ray crystal-
lography, as is the case in this study, a pseudo atomic model can
be built by integrating the subnanometer resolution cryo-EM
density map with the results from widely available comparative
modeling techniques (Topf et al., 2006). This approach repre-
sents an attractive alternative to de novo atomic modeling that
would require 3 A˚ resolution structure determination, which, 104–114, January 2008 ª2008 Elsevier Ltd All rights reserved 109
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3D Structures of the Human PDC Cores by Cryo-EMFigure 6. Comparison of Human and Pro-
karyotic tE2 Structures and Mechanistic
Model of Human PDC Function
(A–C) The human (purple and red) and A. vinelandii
(gold) (Mattevi et al., 1992) tE2 structures are
superimposed and are shown in three approxi-
mately orthogonal views. The helices (H) and
b strands (S) are numbered consecutively from
the N to C termini. (A) The highly conserved b barrel
region of the tE2 trimers. For clarity, only the inter-
nal b barrel center region of the trimer is shown,
and this region consists of b strands and a flanking
helix from each of the three tE2 subunits. One sub-
unit of human tE2 is colored red. (B and C) Orthog-
onal views of the superposition of the human (pur-
ple) and A. vinelandii (gold) tE2 monomer showing
the most significant structural differences located
in the N-terminal loop and its connected helix (H1),
and the internal hairpin loop. In (C), coenzyme A
(CoA) is shown as a ball-and-stick model to high-
light the location of the conserved active sites in
the two models (Mattevi et al., 1992).
(D) Proposed model of human PDC structural
organization and mechanism for catalysis and
regulation (see details in Movie S3). Six E3BP
dimmers (brown) substitute for 12 E2 subunits
(purple) to form the E2E3BP core as described
(Hiromasa et al., 2004). Around each pentagonal
opening, one E3 and two E1 molecules interact
to form a shell connected to the E2E3BP core
through 50 A˚ linkers. The catalytic intermediates
and regulatory enzymes are transferred through
the ‘‘swinging arm’’ and ‘‘hand-over-hand’’ walk-
ing mechanisms. Abbreviations: E1BD, E1-bind-
ing domain; E3BD, E3-binding domain; LpD, lipoyl
domain.remains technically challenging via cryo-EM single-particle re-
construction today.
Comparison of the Human, Yeast, and Prokaryotic
PDC Structures
We have used cryo-EM to obtain structures of the human PDC
E2 and tE2 cores. To our knowledge, this represents the first
study of any full-length E2 in which a segment of 3D structure
has been resolved beyond the inner core. Key findings in this
study are that the active sites within the IC domain are highly
conserved between the human and prokaryotic tE2 molecules,
but that other exterior regions have very different structures
(Figures 6A–6C), which have relevant functional implications.
There are two structural requirements for the IC domain and its
adjacent linker region of mammalian E2 that do not need to be
met in prokaryotic and yeast E2. The first is binding of the IC do-
main of E3BP to the IC domain of E2. Small-angle X-ray scatter-
ing and analytical ultracentrifuge studies find that the E2 60-mer
is larger than E2E3BP, and that the E2 structure binds more E1
(Hiromasa et al., 2004). This seems to require the E2-related IC
domain of E3BP to be integrated into the inner core. In yeast
PDC the E3BP molecule has been proposed to bind near the
internal tips of the cone-shaped trimers within the pentagonal
openings of the E2 core (Stoops et al., 1997). Consistent with
the observation in yeast PDC, the internal hairpin b strands
that form the inner tips of prokaryotic tE2 become extended110 Structure 16, 104–114, January 2008 ª2008 Elsevier Ltd All righloops in the human molecule, which is probably related to the re-
quirement for human E2 to bind to the C-terminal domain of
E3BP (Rahmatullah et al., 1989b). In fact, the C-terminal domains
of human E2 and E3BP are 49% similar, which is in marked con-
trast to the dissimilarities in the IC domain sequences of yeast E2
and E3BP. As we mentioned above, human E3BP is believed to
integrate into the E2 core by replacing some E2 subunits during
the E2E3BP assembly process. Therefore, it seems that the in-
ternal structural difference between human, yeast, and prokary-
otic E2s may relate to specific structural requirements involved in
E2E3BP assembly.
The second unique feature not required in prokaryotic E2 is the
need to support PDK and PDP in acting efficiently on their E1
substrate. In humans, the enzymatic function of E2 is highly reg-
ulated by the control of four PDK isoforms and two PDP isoforms
(Huang et al., 1998; Roche et al., 2001, 2003). Decreasing the ac-
tivity of PDC by phosphorylation is a critical step in preventing
carbohydrate depletion. In fact, inhibiting the activity of specific
PDK isoforms is an active drug target with therapeutic potential
for treating diabetes, heart ischemia, and cancer (Roche and Hir-
omasa, 2007). Based on E2 and E2E3BP maximally binding 60
and 48 E1, respectively (Hiromasa et al., 2004), it would appear
that two b subunits of the E1-a2b2 tetramer bind one E1-binding
domain of E2 (Figure 1A), as observed with related E1-a2b2 (Ae-
varsson et al., 1999, 2000). The cluster of three phosphorylation
sites of E1 are at the active-site channel in a sunken interfacets reserved
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3D Structures of the Human PDC Cores by Cryo-EMformed between the a and b subunits (Ciszak et al., 2001). PDK
and PDP bind to the L2 domain (Figure 1A) (Liu et al., 1995; Chen
et al., 1996; Roche et al., 2003) that is connected by a 30 amino
acid linker region to the E1-binding domain. With this organiza-
tion, PDK and PDP need to be able to move into the space under
the large a subunits to access the serine residues that undergo
phosphorylation and dephosphorylation. This suggests that the
linker regions connecting IC to the E1-binding domain in mam-
malian E2 must maintain substantial separation. Particularly im-
portant would be the stiffness at the beginning of the linker region
at the IC domain upon E1 binding. Indeed, our findings uncover
structural differences in human E2 that are consistent with meet-
ing these unique requirements.
The most striking difference between our human structure
and the X-ray structure of prokaryotic tE2 is located near the
region connected to the linkers. In particular, the N-terminal H1
helices have different orientations (Figure 6). Interestingly, a re-
cently determined atomic structure of the dihydrolipoamide acyl-
transferase (E2b) component of the mammalian branched-chain
a-ketoacid dehydrogenase complex, which has a cubic archi-
tecture, also shows a disposition of the H1 helix similar to that
revealed in our human tE2 structure (Kato et al., 2006). The
N-terminal segment appears to be forming a foundation for the
stable beginning of the linker segment exterior to the tE2 core.
It seems likely that this is needed to support the stiff linker exten-
sion arising from just above this location in E2. We propose that
this stable base/stiff linker region supports an arrangement of the
bound E1s that is more conducive to the regulation of the E1 ac-
tivity by the kinases and phosphatases. The E2-bound E1s form
an outer shell in the PDC 50 A˚ above the core (Figure 2) (Zhou
et al., 2001b). The E1-binding domain forms the pivot about
which the swinging linker arms holding the L1 and L2 lipoyl
domains move. The first and continuous role is for the lipoyl
domains to shuttle the intermediates of catalysis between the
three catalytic centers, which are equally disposed and located
50 A˚ from the pivot (Zhou et al., 2001b) (Figure 6D). In vivo,
there are 20–30 E1 molecules bound to each core of the mam-
malian PDC, and our cryo-electron tomography studies show
that they self associate to form patch-like E1 clusters (not
shown). The active-site region of E1 is in a sunken cleft between
E1’s a and b subunits; this is also the region that is phosphory-
lated (Ciszak et al., 2003). The second role of the lipoyl domains,
particularly the L2 domain, is to shuttle PDK and PDP1 to this ac-
tive-site region to carry out the kinase and phosphatase reac-
tions. This clearly requires extensive space for the L2-bound
92 kDa kinase dimers and 150 kDa PDP1 to access the E1 active
site region located below the larger and more exterior a subunts,
while E1 is held by the E1-binding domain of E2 via its interior
b subunits at the most interior position (Rahmatullah et al.,
1989a, 1990; Zhou et al., 2001b).
Proposed Model of Human PDC
Functions and Regulation
Based on our observation and previous data regarding the
E2E3BP complex (Hiromasa et al., 2004), we proposed a work-
ing model that accounts for the catalytic and unique regulatory
mechanism of mammalian PDC (Figure 6D; also see Movie
S3). In this model, there are five flexible E2 or E3BP N termini
(i.e., one from E3BP and four from E2 subunits) organized aroundStructure 16each five-fold opening of the core. Among them, one E3BP and
two of the four E2 subunits are likely to be bound by E3 and E1
molecules, respectively. The E3 molecule interacts with E1s to
form the outer shell, and these E1s or E3s are connected to
the IC domains of the E2 or E3BP through the internal linkers.
Although some lipoyl domains shuttle the catalytic intermediates
between active sites by way of the ‘‘swinging arm’’ mechanism
with the E1- or E3-binding domain as a pivot (Zhou et al.,
2001b), the lipoyl domains in the free E2 molecules may rotate
about multiple pivots, including the one near the edge of the
E2 core extended to the linker that connects the E1-binding do-
main. We believe that the latter mode is the key to the efficient
delivery of the regulatory enzymes PDK and PDP (shown as
red balls in the Movie S3) around each PDC (Turkan et al.,
2004). A PDK dimer (1–2 copies per PDC) is proposed to be
transferred by a ‘‘hand-over-hand’’ mechanism between differ-
ent lipoyl domains by alternately holding on to one or two lipoyl
domains (Liu et al., 1995; Hiromasa and Roche, 2003; Roche
et al., 2003). This nondissociative movement would be aided
by the linker-region-supported ‘‘swinging arm’’ mechanism by
either using the E1-binding domain as a pivot (transfer within
the pentagonal opening) or by using the multiple pivots of the
non-E1-bound/unconstrained N terminus of E2 (transfer be-
tween different pentagonal openings) as described above.
EXPERIMENTAL PROCEDURES
Enzyme Preparation and Functional Assay
Human E2 and tE2 samples were prepared as described previously (see Sup-
plemental Data in Hiromasa et al., 2004). Briefly, E2 was expressed in E. coli at
37C to mid-log phase and was purified at 4C. Harvested cells were disrupted
by ultrasonication, and particulate material was removed by centrifugation at
10,000 3 g for 20 min. PEG 8000 (50% wt/vol) was added dropwise to a final
concentration of 8% (vol/vol), and the precipitated protein was removed by
centrifugation. An additional 8% volume of PEG was added, and the precipi-
tate was collected by centrifugation. The 8%–16% PEG precipitate was dis-
solved in 15 ml 50 mM potassium phosphate buffer (pH 7.2) containing
0.5 mM EDTA, 0.2 M ammonium chloride, 1 mM b-mecaptoethanol, and
0.1% Pluronics F68. This fraction was treated with DNase I and was run
through a Sephacryl S-400 HR column (3.03 120 cm). Fractions from the col-
umn were assayed for E2 activity and analyzed by SDS-PAGE; those containing
high E2 activity were combined. E2 was pelleted by ultracentrifugation of the su-
pernatant in a Beckman type 50.1 Ti angle rotor at 35,000 rpm for 4 hr at 4C. The
resuspended pellets were further clarified by centrifugation, and the resulting
supernatant was subsequently applied to a Sephacryl S-400 HR column (2.03
105 cm). Fractions (1.1 ml/tube) were monitored according to their absorbance
at 260 and 280 nm, their E2 activity, as well as their SDS-PAGE profile.
Human tE2 was prepared from scE2, which contains a PreScission site in
the third linker region (see Supplemental Data in Hiromasa et al., 2004).
scE2 was purified as described above. Treatment of scE2 with the PreScission
protease (Amersham Biosciences) removed the N-terminal 319 amino acids.
The resulting tE2 was purified by gel filtration with a Sephacryl S-300 HR
column. The assembly of the recombinant molecules into fully functional,
pentagonal, dodecahedral cores was confirmed by a previously described
method and by analytical ultracentrifugation (Yang et al., 1997; Hiromasa
et al., 2004).
Cryo-EM
Cryo-EM of the human E2 and tE2 cores was carried out by following standard
procedures. Briefly, a 3 ml purified sample in a solution containing 0.8 mg/ml E2
or 0.2 mg/ml tE2 was applied to Quantifoil grids with 2 mm diameter holes
(Quantifoil Micro Tools GmbH, Germany) at 4C. The grids were blotted with
filter paper and quickly plunged into liquid-nitrogen-cooled ethane so that
the E2 or tE2 molecules were suspended in vitreous ice. Focal-pair image, 104–114, January 2008 ª2008 Elsevier Ltd All rights reserved 111
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3D Structures of the Human PDC Cores by Cryo-EMframes were acquired by using a JEOL 2010F electron microscope with a field
emission gun operated at 200 kV. This microscope was equipped with a Gatan
Model 626 cryostage and a US4000 4k3 4k CCD camera. Digital cryo-EM im-
ages were recorded at an effective magnification of 69,2503 on the CCD, and
this value corresponds to an effective pixel size of 2.17 A˚/pixel and a specimen
dosage of 12 electrons/A˚2/micrograph. Focal-pair CCD images were re-
corded and preprocessed for translation and rotation correction by using the
JAMES semiautomatic data collection program (Booth et al., 2004). The elec-
tron beam was underfocused, and there was a 2 mm difference between the
close-to-focus (1 mm under focus) and far-from-focus (3 mm under focus)
images. The actual defocus value of each micrograph was determined by us-
ing incoherently averaged Fourier transforms of selected particle images (Zhou
et al., 1996) with the ctfit program (Ludtke et al., 1999).
Computer Image Processing and Reconstruction
Data processing statistics for the 3D reconstructions are summarized in Table 1.
Orientation determination and 3D reconstruction were performed by using
the IMIRS software package (Liang et al., 2002; Zhou and Chiu, 2003) on mul-
tiprocessor MS Windows XP computer workstations from Dell. The orienta-
tions were first estimated from the particle images in the far-from-focus micro-
graphs and were refined to 30 A˚ resolution. These orientation parameters
were then further refined by using the particles in the close-to-focus micro-
graphs. During each step, the particles were classified according to size to
eliminate those particles of larger or smaller diameters. At first, the ‘‘average’’
reconstructions from all particles were used as templates. Each particle image
was then classified into different size groups by intervals of 1%. The 0.99–1.01
size group particles were used for the new reconstructions, which were refined
and used as templates for the next round of size classifications. The above-de-
scribed process was repeated until all of the particles fell within the 0.99–1.01
size group. The correction of contrast transfer function was performed as de-
scribed previously (Zhou and Chiu, 2003), except that varied B factors were
used in the current studies (Table 1). The resolution of the reconstructions
was calculated by using the criterion of Fourier shell correlation coefficient be-
ing greater than 0.5.
Homology Modeling and Cryo-EM Structure-Restrained Refinement
We used the CLUSTALW program (http://www.ebi.ac.uk/clustalw/) to deter-
mine the optimal sequence alignment between human tE2, A. vinelandii tE2
(Mattevi et al., 1992), and B. stearothermophilus tE2 (Izard et al., 1999). We
submitted this alignment, as well as the atomic structure of A. vinelandii tE2
(PDB code: 1EAA), to the SWISS-MODEL automated protein modeling server
(http://www.expasy.org/swissmod/) (Guex and Peitsch, 1997) to obtain a ho-
mology model of human tE2. Although the structures of B. stearothermophilus
and E. faecalis tE2 cores are also available, we did not use either of them as a
template because they are unrefined models based on low-resolution (4.4 A˚)
diffraction data and their backbones are superimposable with that of the
A. vinelandii tE2 structure (Izard et al., 1999).
The preliminary homology model of human tE2 was then aligned by using the
constraints derived from our 8 A˚ cryo-EM density map by maximizing the
agreement of secondary structure elements, including helices, b sheets, and
loops, by using the Chimera package (Pettersen et al., 2004). Briefly, we first
adjusted helices in the homology model by using the interactive segment ad-
justment tools in Chimera to better fit the cryo-EM density based on visual
inspection. The criterion is to enclose as many secondary structure elements
(helices or b sheets) as possible in the envelope of our density map. The pro-
grams Foldhunter (Jiang et al., 2001) and Situs (Wriggers et al., 1999) were also
used to validate the best fit of the enclosed secondary structure elements. This
model is subjected to energy minimization with the SWISS-MODEL server,
leading to a new and improved trial model. The above-described steps are re-
iterated until the root-mean-square deviation (rmsd) of two consecutive trial
models is less than 2.5 A˚ and there is no further improvement in the correlation
between the cryo-EM density map and the model.
Supplemental Data
Supplemental Data include three movies illustrating the human tE2 core struc-
ture and a mechanistic model of human PDC catalysis and regulation, and are
available at http://www.structure.org/cgi/content/full/16/1/104/DC1/.112 Structure 16, 104–114, January 2008 ª2008 Elsevier Ltd All righACKNOWLEDGMENTS
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